CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $163,000 | -62.0% | 33,467 | -11.8% | 0.00% | – |
| Q4 2021 | $429,000 | -23.0% | 37,927 | -0.8% | 0.00% | – |
| Q3 2021 | $557,000 | +76.3% | 38,236 | +40.9% | 0.00% | – |
| Q2 2021 | $316,000 | +29.0% | 27,136 | +35.2% | 0.00% | – |
| Q1 2021 | $245,000 | +22.5% | 20,071 | +25.4% | 0.00% | – |
| Q4 2020 | $200,000 | -13.0% | 16,007 | +4.7% | 0.00% | – |
| Q3 2020 | $230,000 | -44.8% | 15,292 | -10.2% | 0.00% | – |
| Q2 2020 | $417,000 | +154.3% | 17,023 | +47.4% | 0.00% | – |
| Q1 2020 | $164,000 | +92.9% | 11,546 | +14.6% | 0.00% | – |
| Q3 2019 | $85,000 | – | 10,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |